Mark Pruzanski

Shares of Intercept Pharmaceuticals Inc (NASDAQ: ICPT) were trading higher by 5 percent early Friday morning after the company announced the U.S. Food and Drug Administration's Gastrointestinal Drugs Advisory Committee voted to recommend Ocaliva. The committee voted unanimously at 17 to 0...